BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Marksans Pharma Ltd Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
524404
ISIN Demat
INE750C01026
Book Value (Rs)
36.4616629
NSE Symbol
MARKSANS
Divident Yield %
0.27
Market Cap
(Rs In Cr.)
15,090
P/E (TTM)
46.9
EPS (TTM)
7.1
Face Value
(Rs)
1
Back
Marksans Pharma consolidated net profit rises 169.50% in the June 2026 quarter
12-Aug-26   Hrs IST

Net profit of Marksans Pharma rose 169.50% to Rs 157.17 crore in the quarter ended June 2026 as against Rs 58.32 crore during the previous quarter ended June 2025. Sales rose 35.62% to Rs 840.80 crore in the quarter ended June 2026 as against Rs 619.99 crore during the previous quarter ended June 2025.

ParticularsQuarter Ended
Jun. 2026Jun. 2025% Var.
Sales840.80619.99 36
OPM %25.3416.15 -
PBDT231.4499.70 132
PBT206.5776.60 170
NP157.1758.32 169

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)